Similarly, studies of rTMS in cognitive impairment and dyskinesia after stroke have shown that rTMS has an effect on the BDNF‐TrkB receptor pathway in the brain (Guo et al., 2017; Luo et al., 2017). Here, BDNF is linked to drug-induced dyskinesia.